Medicare Enrolled

Dr. Neeraj Agnihotri, MD

Hematology & Oncology · Palmdale, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
38660 MEDICAL CENTER DR, Palmdale, CA 93551
6619485928
In practice since 2007 (18 years)
NPI: 1598951873 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Agnihotri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agnihotri? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Agnihotri

Dr. Neeraj Agnihotri is a hematology & oncology specialist in Palmdale, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Agnihotri performed 556 Medicare services across 297 unique beneficiaries.

Between the years covered by Open Payments, Dr. Agnihotri received a total of $4,249 from 39 pharmaceutical and/or device companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Agnihotri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 556 Medicare services $4,249 industry payments

Medicare Practice Summary

Medicare Utilization ↗
556
Medicare services
Bottom 37% in CA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
297
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~31 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
287 $96 $261
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
70 $140 $504
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
65 $114 $426
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
59 $76 $175
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
51 $88 $266
New patient office visit, complex (60-74 min) 24 $176 $469
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,249
Total received (2018-2024)
Avg $607/year across 7 years
Top 46% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
246
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,760 (88.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$490 (11.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$203
2023
$420
2022
$468
2021
$130
2020
$450
2019
$1,305
2018
$1,273

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$45
Astellas Pharma US Inc
$43
ADC Therapeutics America, Inc.
$26
E.R. Squibb & Sons, L.L.C.
$26
Celgene Corporation
$24
Daiichi Sankyo Inc.
$21
PFIZER INC.
$18
Top 3 companies account for 56.1% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$825
E.R. Squibb & Sons, L.L.C.
$624
Novartis Pharmaceuticals Corporation
$452
PFIZER INC.
$448
Amgen Inc.
$267
Janssen Biotech, Inc.
$243
Astellas Pharma US Inc
$168
Daiichi Sankyo Inc.
$122
Dendreon Pharmaceuticals LLC
$92
AstraZeneca Pharmaceuticals LP
$89
Merck Sharp & Dohme Corporation
$73
Foundation Medicine, Inc.
$72
GENZYME CORPORATION
$67
EMD Serono, Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$48
EISAI INC.
$48
Medtronic, Inc.
$45
Eisai Inc.
$40
ADC Therapeutics America, Inc.
$39
TESARO, Inc.
$38
Bayer HealthCare Pharmaceuticals Inc.
$36
Gilead Sciences, Inc.
$32
Kite Pharma, Inc.
$30
GlaxoSmithKline, LLC.
$25
Celgene Corporation
$24
Rigel Pharmaceuticals, Inc.
$24
Exelixis Inc.
$22
Seagen Inc.
$22
Galvanize Therapeutics, Inc
$21
Advanced Accelerator Applications
$20
Stemline Therapeutics Inc.
$20
Lilly USA, LLC
$19
Medtronic USA, Inc.
$18
TAIHO ONCOLOGY, INC.
$17
INSYS Therapeutics Inc
$16
Becton, Dickinson and Company
$15
Mirati Therapeutics, Inc.
$14
Janssen Pharmaceuticals, Inc
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Top 3 companies account for 44.7% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · AFINITOR · ALIYA SYSTEM · Alecensa · Avastin · BAVENCIO · BESPONSA · BOSULIF · Bavencio · CABLIVI · CABOMETYX · DARZALEX · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · Erleada · FOUNDATIONONE · GILOTRIF · Halaven · Herceptin · IBRANCE · IMFINZI · INJECTAFER · INLYTA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KYPHON Balloon Kyphoplasty · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · Lenvima · MEKINIST · MYLOTARG · OPDIVO · OSTEOCOOL RF ABLATION SYSTEM · Orserdu · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · REYATAZ · RYBREVANT · RYDAPT · SCEMBLIX · SUTENT · SYNDROS · Stivarga · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TIVDAK · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · Vanflyta · Vyloy · XALATAN · XALKORI · XTANDI · Xospata · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Palmdale?
Compare hematology & oncology specialists in the Palmdale area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
18
Per 100K population
0.2
County median income
$87,760
Nearest hospital
ANTELOPE VALLEY HOSPITAL
9.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Agnihotri is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Agnihotri experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Agnihotri performed 287 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Agnihotri receive payments from pharmaceutical companies?
Yes. Dr. Agnihotri received a total of $4,249 from 39 companies across 246 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agnihotri's costs compare to other hematology & oncology specialists in Palmdale?
Dr. Agnihotri's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agnihotri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →